ITMCTR2024000059
Recruiting
Phase 4
Clinical study on the effectiveness and safety of wound healing after low anal fistula
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD
Conditionsarchosyrinx
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- archosyrinx
- Sponsor
- Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Age: 18 to 65 years old (including 18,65 years old);
- •(2\) In line with the western medicine diagnosis of low\-grade anal fistula;
- •(3\) Diagnosis of TCM syndrome under dampness and heat of anal leakage;
- •(4\) Prepare to be treated by anal fistula resection;
- •(5\) On the basis of the informed study purpose, voluntarily participate in the study, and sign the informed consent form.
Exclusion Criteria
- •(1\) Abnormal blood, urine, stool examination, liver and kidney function, coagulation function examination and clinical significance;
- •(2\) Patients with severe cardiovascular and cerebrovascular diseases, diabetes and bone marrow, pelvic floor nerve diseases, mental illness and other systemic diseases;
- •(3\) Patients with anorectal tumor disease, inflammatory bowel disease, perianal skin disease and other peripheral related diseases;
- •(4\) Abnormal anal morphology, structure, or impaired anal function;
- •(5\) Those who are allergic to the components of the test drug;
- •(6\) women in pregnancy or lactation;
- •(7\) They are not considered suitable by the investigator to participate in this clinical trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Clinical study of the safety and effectiveness of two hyaluronic acid injectable products (MaiLi Precise® and MaiLi Define®) as fillers in the treatment of lip thinness and wrinkles around the mouthISRCTN30768206Sinclair Pharma68
Completed
Not Applicable
Clinical study of the safety and effectiveness of the use of two hyaluronic acid injectable products (MaiLi Precise® and MaiLi Define®) in the treatment of facial skin depressions of the mid-faceFor MaiLi Precise® treatment: mild to moderate nasolabial folds and/or subjects with mild to moderate tear trough. For MaiLi Define® treatment: moderate to severe nasolabial folds and/or moderate to severe marionette lines.Skin and Connective Tissue DiseasesISRCTN10761529Sinclair Pharma68
Completed
Not Applicable
A clinical study on the efficacy and safety of the scent of essential oils for depressiodepressive stateJPRN-UMIN000051570Okinawa Prefecture10
Completed
Not Applicable
Clinical study for the safety and effectiveness of the use of Perfectha® Derm lidocaine in the treatment of medium wrinklesISRCTN20356582Sinclair Pharma70
Not yet recruiting
Not Applicable
A clinical trial of herbal products in the management of knee osteoarthritisHealth Condition 1: M179- Osteoarthritis of knee, unspecifiedCTRI/2024/06/069519Phytoveda Pvt Ltd